Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
Clinical trial NCT00847379 · TERMINATED
Trial details
- NCT number
- NCT00847379
- Sponsor
- PTC Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-31
- Primary completion
- 2010-05-24
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.